PeptideStack
5.2kquestions
20kanswers
220users

If I reconstitute a 50 mg vial with 2 mL of phosphate-buffered diluent, what concentration do I end up with?

Asked 10 Oct 2025Modified 6 months agoViewed 14k times
7

The particulars: 50 mg · 2 mL · phosphate-buffered diluent.

I would rather understand the derivation than memorise the outcome.

Two people I asked gave two answers that differ by a factor of ten, which is suggestive.

Can someone walk through the arithmetic step by step?

reconstitution
reconstitution

Taking a lyophilised vial to a solution of known concentration: choice of diluent, volume selection, how to add liquid without shearing the cake,…

330 questions
diluent-volume
diluent-volume

Choosing how much diluent to add, which is really a question about what you want your measurement resolution to be. Larger volumes buy you…

308 questions
dosing-math
dosing-math

The arithmetic itself: milligrams to millilitres to insulin units, concentration after reconstitution, dose per draw, and vial-days per vial. Show…

811 questions
shareeditfollowflag
TG
askedtandem_gradient85k24810 Oct 2025

5 Answers

Accepted answer first, then by votes
29

Accepted answer

The distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.

On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.

Concentration and unit conversion at a glance

VialDiluentConcentration0.25 mg0.5 mg1 mg2.5 mg
5 mg1 mL5 mg/mL5 u10 u20 u50 u
5 mg2 mL2.5 mg/mL10 u20 u40 u100 u
10 mg1 mL10 mg/mL2.5 u5 u10 u25 u
10 mg2 mL5 mg/mL5 u10 u20 u50 u
10 mg3 mL3.33 mg/mL7.5 u15 u30 u75 u

Units are U-100 insulin units, where 1 unit = 0.01 mL. Divide dose by concentration for millilitres, then multiply by 100.

Stated carefully, do not use the same needle to pierce the stopper and to administer.

The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

edited 24 Jan 2026 by h_pergande — added the placebo-arm figures

shareimprove this answerflag
HP
answered · acceptedh_pergande86k2583 Jan 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
11

This is not exotic. It is just the difference between doing it deliberately and doing it approximately.

Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.

Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.

Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.

Do the arithmetic twice, ideally with someone else doing it independently.

edited 25 Dec 2025 by lipid_panel_q — fixed an arithmetic slip in the third paragraph

shareimprove this answerflag
LQ
answeredlipid_panel_q44k13823 Dec 2025
7

Read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.

Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.

Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.

None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.

shareimprove this answerflag
PH
answeredpetra_hovland42k3812 Dec 2025
5Note that the label instructions differ between agents on precisely this point. – sinead_gaffney 3 months ago
add a comment
6

Reconstitution is the step where most hands-on errors enter the system, which is why spending time on technique here pays off more than anywhere else.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.

Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.

The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.

The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.

shareimprove this answerflag
SK
answereds_kalniete47k381 Dec 2025
3I would add a sentence about sterility here, since it is the thing people skip. – h_pergande 5 months ago
4The placebo-arm figure is the part everyone omits. – Dr_Malik_Osei 7 months ago
add a comment
4

Add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.

Number of stopper piercings matters less than the gauge doing the piercing.

Do the arithmetic twice, ideally with someone else doing it independently.

shareimprove this answerflag
MF
answeredmeniscus_film34k3820 Oct 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.